Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells

FEBS Letters
Nianli LiuHaizhen Zhu

Abstract

To investigate TRAIL resistance mechanisms in hepatocellular carcinoma (HCC), we isolated a stable TRAIL-resistant sub-population of the HCC cell line LH86, designated LH86-TR. Differential activation of AKT was not responsible for acquisition of TRAIL resistance. Cells with both congenital and acquired resistance to TRAIL exhibited increased Msi1 expression, which conferred TRAIL resistance by activating ERK. Forced expression of Msi1 decreased the sensitivity of HCC cells to TRAIL both in vitro and in vivo. Conversely, shRNA-mediated depletion of Msi1 enhanced TRAIL efficacy. SiRNA-mediated depletion of ERK overcame TRAIL resistance. Hence, we conclude that Msi1 is a mediator of TRAIL resistance in HCC cells.

References

Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas S SöderströmJohn E Eriksson
Jun 1, 2005·Experimental Cell Research·Hideyuki OkanoTakao Imai
Nov 14, 2006·Biochemical and Biophysical Research Communications·Tae-Jin LeeTaeg Kyu Kwon
May 13, 2008·Gastroenterology·Sripathi M SurebanCourtney W Houchen
Oct 2, 2008·BMC Cancer·Patricia C Sanchez-DiazLuiz O F Penalva
Mar 5, 2009·The Journal of Biological Chemistry·Raquel de Sousa AbreuLuiz O F Penalva
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Giulia BertoliniGabriella Sozzi
Mar 4, 2010·Molecular Cancer Therapeutics·Shengbing Huang, Frank A Sinicrope
Mar 4, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey WiezorekJonathan Graves
Jun 10, 2010·Oncogene·F Gonzalvez, A Ashkenazi
Oct 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kuen-Feng ChenAnn-Lii Cheng
Dec 18, 2010·International Journal of Cancer. Journal International Du Cancer·Martin GötteOlaf Buchweitz
May 30, 2013·Oncotarget·Xiao-Yang WangRobert I Glazer
Jan 22, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Kunlun ChenXin Xu
Feb 13, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chun-Han ChenChe-Ming Teng
Apr 17, 2014·Cancer Cell·Jens U Marquardt, Snorri S Thorgeirsson
Jun 21, 2014·Cell Death and Differentiation·J LemkeH Walczak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.